{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:25:27Z","timestamp":1793701527268,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71367-2","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:36:11Z","timestamp":1775522171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteoarthritis and analgesic consumption in haemochromatosis HFE C282Y homozygotes with normal or low iron parameters"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-8187","authenticated-orcid":false,"given":"Jens","family":"Helby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-2618","authenticated-orcid":false,"given":"Mathis","family":"Mottelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-4133","authenticated-orcid":false,"given":"Stig Egil","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Faurschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-5114","authenticated-orcid":false,"given":"Jesper","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-4375","authenticated-orcid":false,"given":"Christina","family":"Ellervik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Warny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2082-0738","authenticated-orcid":false,"given":"Andreas","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"71367_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/03009742.2016.1155645","volume":"46","author":"A Richardson","year":"2017","unstructured":"Richardson, A., Prideaux, A. & Kiely, P. Haemochromatosis: unexplained metacarpophalangeal or ankle arthropathy should prompt diagnostic tests: findings from two UK observational cohort studies. Scand. J. Rheumatol. 46, 69\u201374 (2017).","journal-title":"Scand. J. Rheumatol."},{"key":"71367_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jhep.2022.03.033","volume":"77","author":"H Zoller","year":"2022","unstructured":"Zoller, H. et al. EASL clinical practice guidelines on haemochromatosis. J. Hepatol. 77, 479\u2013502 (2022).","journal-title":"J. Hepatol."},{"key":"71367_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0002-9343(99)00120-5","volume":"106","author":"SM Mcdonnell","year":"1999","unstructured":"Mcdonnell, S. M. et al. A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am. J. Med. 106, 619\u2013624 (1999).","journal-title":"Am. J. Med"},{"key":"71367_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/ard.2006.063099","volume":"66","author":"BZ Alizadeh","year":"2007","unstructured":"Alizadeh, B. Z. et al. The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann. Rheum. Dis. 66, 1436\u20131442 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"71367_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth, E. & Ganz, T. Hepcidin and iron in health and disease. Annu Rev. Med. 74, 261\u2013277 (2023).","journal-title":"Annu Rev. Med"},{"key":"71367_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa073286","volume":"358","author":"KJ Allen","year":"2008","unstructured":"Allen, K. J. et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358, 221\u2013230 (2008).","journal-title":"N. Engl. J. Med"},{"key":"71367_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/hep.32575","volume":"76","author":"LC Pilling","year":"2022","unstructured":"Pilling, L. C., Atkins, J. L. & Melzer, D. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: associations in a large community cohort. Hepatology 76, 1735\u20131745 (2022).","journal-title":"Hepatology"},{"key":"71367_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1159\/000444549","volume":"34","author":"H Zoller","year":"2016","unstructured":"Zoller, H. & Henninger, B. Pathogenesis, diagnosis and treatment of hemochromatosis. Digestive Dis. 34, 364\u2013373 (2016).","journal-title":"Digestive Dis."},{"key":"71367_CR9","doi-asserted-by":"crossref","unstructured":"The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut. 41, 841\u2013844 (1997).","DOI":"10.1136\/gut.41.6.841"},{"key":"71367_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bjh.15164","volume":"181","author":"EJ Fitzsimons","year":"2018","unstructured":"Fitzsimons, E. J., Cullis, J. O., Thomas, D. W., Tsochatzis, E. & Griffiths, W. J. H. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). Br. J. Haematol. 181, 293\u2013303 (2018).","journal-title":"Br. J. Haematol."},{"key":"71367_CR11","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1182\/blood.2021011338","volume":"139","author":"D Girelli","year":"2022","unstructured":"Girelli, D. et al. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood 139, 3018\u20133029 (2022).","journal-title":"Blood"},{"key":"71367_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.24330","volume":"54","author":"BR Bacon","year":"2011","unstructured":"Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W. & Tavill, A. S. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American association for the study of liver diseases. Hepatology 54, 328\u2013343 (2011).","journal-title":"Hepatology"},{"key":"71367_CR13","doi-asserted-by":"publisher","first-page":"e079147","DOI":"10.1136\/bmj-2023-079147","volume":"387","author":"M Mottelson","year":"2024","unstructured":"Mottelson, M. et al. Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study. BMJ 387, e079147 (2024).","journal-title":"BMJ"},{"key":"71367_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1182\/blood.2023022235","volume":"144","author":"M Mottelson","year":"2024","unstructured":"Mottelson, M. et al. Iron, hemochromatosis genotypes, and risk of infections: a cohort study of 142 188 general population individuals. Blood 144, 693\u2013707 (2024).","journal-title":"Blood"},{"key":"71367_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/ard.2009.120204","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland, G. R. et al. Synovial immunopathology in haemochromatosis arthropathy. Ann. Rheum. Dis. 69, 1214\u20131219 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"71367_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/art.30094","volume":"63","author":"GJ Carroll","year":"2011","unstructured":"Carroll, G. J., Breidahl, W. H., Bulsara, M. K. & Olynyk, J. K. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum. 63, 286\u2013294 (2011).","journal-title":"Arthritis Rheum."},{"key":"71367_CR17","doi-asserted-by":"publisher","first-page":"817104","DOI":"10.3389\/fcell.2021.817104","volume":"9","author":"C Cai","year":"2022","unstructured":"Cai, C., Hu, W. & Chu, T. Interplay between iron overload and osteoarthritis: clinical significance and cellular mechanisms. Front Cell Dev. Biol. 9, 817104 (2022).","journal-title":"Front Cell Dev. Biol."},{"key":"71367_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/liv.15797","volume":"44","author":"B Schaefer","year":"2024","unstructured":"Schaefer, B. et al. Penetrance, cancer incidence and survival in HFE haemochromatosis\u2014a population-based cohort study. Liver Int. 44, 838\u2013847 (2024).","journal-title":"Liver Int."},{"key":"71367_CR19","doi-asserted-by":"crossref","unstructured":"Husar-Memmer, E., Stadlmayr, A., Datz, C. & Zwerina, J. HFE-related hemochromatosis: an update for the rheumatologist. Curr. Rheumatol. Rep. 16, 393 (2014).","DOI":"10.1007\/s11926-013-0393-4"},{"key":"71367_CR20","doi-asserted-by":"publisher","first-page":"k5222","DOI":"10.1136\/bmj.k5222","volume":"364","author":"LC Pilling","year":"2019","unstructured":"Pilling, L. C. et al. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ 364, k5222 (2019).","journal-title":"BMJ"},{"key":"71367_CR21","volume":"7","author":"LR Banfield","year":"2023","unstructured":"Banfield, L. R., Knapp, K. M., Pilling, L. C., Melzer, D. & Atkins, J. L. Hemochromatosis genetic variants and musculoskeletal outcomes: 11.5-year follow-up in the UK biobank cohort study. JBMR 7, e10794 (2023).","journal-title":"JBMR"},{"key":"71367_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-373","volume":"15","author":"S Kou","year":"2014","unstructured":"Kou, S. & Wu, Y. Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk. BMC Musculoskelet. Disord. 15, 373 (2014).","journal-title":"BMC Musculoskelet. Disord."},{"key":"71367_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4132\/KoreanJPathol.2012.46.1.30","volume":"46","author":"L Han","year":"2012","unstructured":"Han, L. et al. TNF-a and TNF-\u03b2 Polymorphisms are Associated with Susceptibility to Osteoarthritis in a Korean Population. Korean J. Pathol. 46, 30\u201337 (2012).","journal-title":"Korean J. Pathol."},{"key":"71367_CR24","doi-asserted-by":"crossref","unstructured":"Nixon, A. M., Neely, E., Simpson, I. A. & Connor, J. R. The role of HFE genotype in macrophage phenotype. J. Neuroinflammation. 15, 30 (2018).","DOI":"10.1186\/s12974-018-1057-0"},{"key":"71367_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3324\/haematol.2019.235630","volume":"106","author":"NK Tangudu","year":"2021","unstructured":"Tangudu, N. K. et al. Macrophage-HFE controls iron metabolism and immune responses in aged mice. Haematologica 106, 259\u2013263 (2021).","journal-title":"Haematologica"},{"key":"71367_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood-2018-02-830562","volume":"132","author":"K Sandhu","year":"2018","unstructured":"Sandhu, K. et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood 132, 101\u2013110 (2018).","journal-title":"Blood"},{"key":"71367_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1046\/j.1365-2141.2002.03509.x","volume":"117","author":"M De Gobbi","year":"2002","unstructured":"De Gobbi, M. et al. Natural history of juvenile haemochromatosis. Br. J. Haematol. 117, 973\u2013979 (2002).","journal-title":"Br. J. Haematol."},{"key":"71367_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/art.10755","volume":"48","author":"G Vaiopoulos","year":"2003","unstructured":"Vaiopoulos, G. et al. Arthropathy in juvenile hemochromatosis. Arthritis Rheum. 48, 227\u2013230 (2003).","journal-title":"Arthritis Rheum."},{"key":"71367_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.23333","volume":"51","author":"AL Fracanzani","year":"2010","unstructured":"Fracanzani, A. L. et al. Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology 51, 501\u2013510 (2010).","journal-title":"Hepatology"},{"key":"71367_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4997\/jrcpe.2018.307","volume":"48","author":"PDW Kiely","year":"2018","unstructured":"Kiely, P. D. W. Haemochromatosis arthropathy \u2013 a conundrum of the celtic curse. J. R. Coll. Physicians Edinb. 48, 233\u2013238 (2018).","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"71367_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge, E., Sandegaard, J. L. & Rebolj, M. The Danish national patient register. Scand. J. Public Health 39, 30\u201333 (2011).","journal-title":"Scand. J. Public Health"},{"key":"71367_CR32","unstructured":"Kiely, P. D. et al. EULAR 2025 classification criteria for haemochromatosis arthropathy. Ann. Rheum Dis. 85, 238\u2013245 (2026)."},{"key":"71367_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/CLEP.S311450","volume":"13","author":"N Gaster","year":"2021","unstructured":"Gaster, N., Hallas, J., Potteg\u00e5rd, A., Friis, S. & Schmidt, M. The validity of Danish prescription data to measure use of aspirin and other non-steroidal anti-inflammatory drugs and quantification of bias due to non-prescription drug use. Clin. Epidemiol. 13, 569\u2013579 (2021).","journal-title":"Clin. Epidemiol."},{"key":"71367_CR34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3324\/haematol.2016.161943","volume":"102","author":"J Helby","year":"2017","unstructured":"Helby, J., Nordestgaard, B. G., Benfield, T. & Bojesen, S. E. Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population. Haematologica 102, 1457\u20131465 (2017).","journal-title":"Haematologica"},{"key":"71367_CR35","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","volume":"396","author":"MB Mortensen","year":"2020","unstructured":"Mortensen, M. B. & Nordestgaard, B. G. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet 396, 1644\u20131652 (2020).","journal-title":"Lancet"},{"key":"71367_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1308027","volume":"371","author":"AB J\u00f8rgensen","year":"2014","unstructured":"J\u00f8rgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G. & Tybj\u00e6rg-Hansen, A. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N. Engl. J. Med. 371, 32\u201341 (2014).","journal-title":"N. Engl. J. Med"},{"key":"71367_CR37","first-page":"A4693","volume":"60","author":"HKM Bergholdt","year":"2013","unstructured":"Bergholdt, H. K. M. et al. Study design, participation and characteristics of the Danish General Suburban Population Study. Dan. Med. J. 60, A4693 (2013).","journal-title":"Dan. Med. J."},{"key":"71367_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1373\/clinchem.2017.276055","volume":"64","author":"IW Moen","year":"2018","unstructured":"Moen, I. W., Bergholdt, H. K. M., Mandrup-Poulsen, T., Nordestgaard, B. G. & Ellervik, C. Increased plasma ferritin concentration and low-grade inflammation-a mendelian randomization study. Clin. Chem. 64, 374\u2013385 (2018).","journal-title":"Clin. Chem."},{"key":"71367_CR39","first-page":"441","volume":"53","author":"CB Pedersen","year":"2006","unstructured":"Pedersen, C. B., G\u00f8tzsche, H., M\u00f8ller, J. O. & Mortensen, P. B. The Danish civil registration system. a cohort of eight million persons. Dan. Med Bull. 53, 441\u2013449 (2006).","journal-title":"Dan. Med Bull."},{"key":"71367_CR40","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.joca.2011.07.009","volume":"19","author":"KT J\u00f8rgensen","year":"2011","unstructured":"J\u00f8rgensen, K. T. et al. Socio-demographic factors, reproductive history and risk of osteoarthritis in a cohort of 4.6 million Danish women and men. Osteoarthr. Cartil. 19, 1176\u20131182 (2011).","journal-title":"Osteoarthr. Cartil."},{"key":"71367_CR41","doi-asserted-by":"publisher","first-page":"e5244","DOI":"10.1136\/bmj.e5244","volume":"345","author":"SF Nielsen","year":"2012","unstructured":"Nielsen, S. F., Bojesen, S. E., Schnohr, P. & Nordestgaard, B. G. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345, e5244 (2012).","journal-title":"BMJ"},{"key":"71367_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.14740\/gr1206","volume":"12","author":"NT Milman","year":"2019","unstructured":"Milman, N. T., Schioedt, F. V., Junker, A. E. & Magnussen, K. Diagnosis and treatment of genetic HFE -hemochromatosis: the Danish aspect. Gastroenterol. Res. 12, 221\u2013232 (2019).","journal-title":"Gastroenterol. Res"},{"key":"71367_CR43","first-page":"V09180619","volume":"180","author":"NT Milman","year":"2018","unstructured":"Milman, N. T. et al. Genetic HFE-haemochromatosis. Ugeskr. Laege 180, V09180619 (2018).","journal-title":"Ugeskr. Laege"},{"key":"71367_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"H Wallach Kildemoes","year":"2011","unstructured":"Wallach Kildemoes, H., Toft S\u00f8rensen, H. & Hallas, J. The Danish national prescription registry. Scand. J. Public Health 39, 38\u201341 (2011).","journal-title":"Scand. J. Public Health"},{"key":"71367_CR45","doi-asserted-by":"publisher","first-page":"e074450","DOI":"10.1136\/bmj-2022-074450","volume":"382","author":"A Meaidi","year":"2023","unstructured":"Meaidi, A. et al. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: Nationwide cohort study. BMJ 382, e074450 (2023).","journal-title":"BMJ"},{"key":"71367_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/JPR.S388674","volume":"16","author":"CA Hansen","year":"2023","unstructured":"Hansen, C. A., Abrahamsen, B., Ernst, M. T. & Smith, C. D. Epidemiological factors associated with prescription of opioids for chronic non-cancer pain in adults: a country-wide, registry-based study in Denmark spans 2004\u20132018. J. Pain. Res. 16, 463\u2013485 (2023).","journal-title":"J. Pain. Res"},{"key":"71367_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman, D. G. & Bland, J. M. Interaction revisited: the difference between two estimates. BMJ 326, 219 (2003).","journal-title":"BMJ"},{"key":"71367_CR48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"71367_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081926","volume":"14","author":"MR Lucas","year":"2024","unstructured":"Lucas, M. R., Atkins, J. L., Pilling, L. C., Shearman, J. D. & Melzer, D. HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. BMJ Open 14, e081926 (2024).","journal-title":"BMJ Open"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71367-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71367-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71367-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:03:46Z","timestamp":1780531426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71367-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71367"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71367-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.G. received a research grant from Novo Nordisk for the submitted work. Without direct relation to the submitted work: A.G. received research funding from Agios, Bristol Myers Squibb, Novo Nordisk and Sanofi, and payment for consultancy work and\/or advisory board participation from Agios, Vertex Pharmaceuticals, Pharmacosmos, Novo Nordisk, and Disc Medicine; J.H. received research funding, payment for advisory board participation, and a conference travel grant from Sanofi and payment for advisory board participation from Disc Medicine. C.E. is partly funded by the Laboratory Medicine Endowment Fund at Boston Children\u2019s Hospital, USA. All other authors declare no relevant competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4926"}}